Literature DB >> 7358978

Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides.

A R Anwar, J R McKean, S R Smithers, A B Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7358978

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  22 in total

1.  Identification of C3 beta chain as the human serum eosinophil cytotoxicity inhibitor.

Authors:  M S Minkoff; W W Wong; D S Silberstein
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

2.  Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes.

Authors:  R Moqbel; A J MacDonald; A B Kay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  Differential contribution of chemotaxins and opsonins to neutrophil-mediated killing of Schistosoma mansoni larvae.

Authors:  C H King; P J Spagnuolo; J J Ellner
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.

Authors:  R Moqbel; A J Macdonald; O Cromwell; A B Kay
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

5.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 6.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

7.  Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro.

Authors:  R Moqbel; A J MacDonald; A B Kay
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

8.  Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils.

Authors:  A B Kay; G M Walsh
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

9.  Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.

Authors:  M Miyasato; S Tsuda; M Kasada; K Iryo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by cloned mouse mast cells and granule-containing lymphoid cells.

Authors:  A M Dvorak; S J Klebanoff; W R Henderson; R A Monahan; K Pyne; S J Galli
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.